Metabolic injury to axons and myelin

Experimental Neurology

Volumn 246, Issue , 2013, Pages 26-34

  Tsutsui, Shigeki ^a   Stys, Peter K ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Axon; Ca stores; Calcium; Glutamate; Myelin

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMPA RECEPTOR; CALCIUM; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CALPAIN; CASPASE 3; CYTOCHROME C; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; G PROTEIN COUPLED RECEPTOR; GLUCOSE; GLUTAMIC ACID; KAINIC ACID RECEPTOR; MYELIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR; OXYGEN; PHOSPHOLIPASE C; SODIUM; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM PROTON EXCHANGE PROTEIN; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

AXONAL INJURY; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN METABOLISM; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CENTRAL NERVOUS SYSTEM; CHANNEL GATING; DEMYELINATION; ENERGY METABOLISM; ENZYME ACTIVATION; GLIA CELL; GLUCOSE TRANSPORT; HUMAN; NERVE CELL DEGENERATION; NERVE CELL MEMBRANE STEADY POTENTIAL; NEUROLOGIC DISEASE; NEUROTRANSMITTER RELEASE; NEUROTRANSMITTER UPTAKE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SODIUM CELL LEVEL; WHITE MATTER; WHITE MATTER INJURY;

AXON; CA STORES; CALCIUM; GLUTAMATE; MYELIN;

ANIMALS; AXONS; CALCIUM; ENERGY METABOLISM; HUMANS; MYELIN SHEATH; NERVE FIBERS, MYELINATED;

EID: 84879799839     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.04.016     Document Type: Review

References (172)

1. Aboitiz F., Scheibel A.B., Fisher R.S., Zaidel E. Fiber composition of the human corpus callosum. Brain Res. 1992, 598:143-153.
2. Acosta-Cabronero J., Williams G.B., Pengas G., Nestor P.J. Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease. Brain 2010, 133:529-539.
3. 2+ exchanger. J. Neurosci. 1996, 16:545-552.
4. Alix J.J., Dolphin A.C., Fern R. Vesicular apparatus, including functional calcium channels, are present in developing rodent optic nerve axons and are required for normal node of Ranvier formation. J. Physiol. 2008, 586:4069-4089.
5. Arluison M., Quignon M., Thorens B., Leloup C., Penicaud L. Immunocytochemical localization of the glucose transporter 2 (GLUT2) in the adult rat brain. II. Electron microscopic study. J. Chem. Neuroanat. 2004, 28:137-146.
6. Arranz A.M., Hussein A., Alix J.J., Perez-Cerda F., Allcock N., Matute C., Fern R. Functional glutamate transport in rodent optic nerve axons and glia. Glia 2008, 56:1353-1367.
7. Bakiri Y., Burzomato V., Frugier G., Hamilton N.B., Karadottir R., Attwell D. Glutamatergic signaling in the brain's white matter. Neuroscience 2009, 158:266-274.
8. Banik N.L., Matzelle D.C., Gantt W.G., Osborne A., Hogan E.L. Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury. Brain Res. 1997, 752:301-306.
9. 2+ exchanger in excitotoxicity. Cell 2005, 120:275-285.
10. 2+ store in the plasticity of central neurons. Trends Pharmacol. Sci. 2006, 27:78-84.
11. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol. Rev. 1999, 79:1127-1155.
12. Bi X., Tocco G., Baudry M. Calpain-mediated regulation of AMPA receptors in adult rat brain. Neuroreport 1994, 6:61-64.
13. Bi X., Rong Y., Chen J., Dang S., Wang Z., Baudry M. Calpain-mediated regulation of NMDA receptor structure and function. Brain Res. 1998, 790:245-253.
14. Birnbaum M.J., Haspel H.C., Rosen O.M. Cloning and characterization of a cDNA encoding the rat brain glucose-transporter protein. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:5784-5788.
15. Blaustein M.P., Juhaszova M., Golovina V.A., Church P.J., Stanley E.F. Na/Ca exchanger and PMCA localization in neurons and astrocytes: functional implications. Ann. N. Y. Acad. Sci. 2002, 976:356-366.
16. Brown A.M., Ransom B.R. Astrocyte glycogen and brain energy metabolism. Glia 2007, 55:1263-1271.
17. Brown A.M., Westenbroek R.E., Catterall W.A., Ransom B.R. Axonal L-type Ca(2+) channels and anoxic injury in rat CNS white matter. J. Neurophysiol. 2001, 85:900-911.
18. Brown A.M., Baltan Tekkok S., Ransom B.R. Energy transfer from astrocytes to axons: the role of CNS glycogen. Neurochem. Int. 2004, 45:529-536.
19. Burzomato V., Frugier G., Perez-Otano I., Kittler J.T., Attwell D. The receptor subunits generating NMDA receptor mediated currents in oligodendrocytes. J. Physiol. 2010, 588:3403-3414.
20. Chen Y.Q., Rafi M.A., de Gala G., Wenger D.A. Cloning and expression of cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophy. Hum. Mol. Genet. 1993, 2:1841-1845.
21. Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat. Rev. Neurosci. 2005, 6:889-898.
22. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
23. Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S., Littman D.R., Dustin M.L., Gan W.B. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 2005, 8:752-758.
24. De Biase L.M., Nishiyama A., Bergles D.E. Excitability and synaptic communication within the oligodendrocyte lineage. J. Neurosci. 2010, 30:3600-3611.
25. De Biase L.M., Kang S.H., Baxi E.G., Fukaya M., Pucak M.L., Mishina M., Calabresi P.A., Bergles D.E. NMDA receptor signaling in oligodendrocyte progenitors is not required for oligodendrogenesis and myelination. J. Neurosci. 2011, 31:12650-12662.
26. De Blasi A., Conn P.J., Pin J., Nicoletti F. Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol. Sci. 2001, 22:114-120.
27. Deng W., Rosenberg P.A., Volpe J.J., Jensen F.E. Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:6801-6806.
28. Deshpande R.V., Goust J.M., Hogan E.L., Banik N.L. Calpain secreted by activated human lymphoid cells degrades myelin. J. Neurosci. Res. 1995, 42:259-265.
29. Diaz-Sanchez M., Williams K., DeLuca G.C., Esiri M.M. Protein co-expression with axonal injury in multiple sclerosis plaques. Acta Neuropathol. 2006, 111:289-299.
30. Domercq M., Sanchez-Gomez M.V., Areso P., Matute C. Expression of glutamate transporters in rat optic nerve oligodendrocytes. Eur. J. Neurosci. 1999, 11:2226-2236.
31. Domercq M., Perez-Samartin A., Aparicio D., Alberdi E., Pampliega O., Matute C. P2X7 receptors mediate ischemic damage to oligodendrocytes. Glia 2010, 58:730-740.
32. Duelli R., Kuschinsky W. Brain glucose transporters: relationship to local energy demand. News Physiol. Sci. 2001, 16:71-76.
33. Etxeberria A., Mangin J.M., Aguirre A., Gallo V. Adult-born SVZ progenitors receive transient synapses during remyelination in corpus callosum. Nat. Neurosci. 2010, 13:287-289.
34. Felts P.A., Smith K.J. Changes in the distribution of a calcium-dependent ATPase during demyelination and remyelination in the central nervous system. J. Neurocytol. 1996, 25:171-180.
35. Fern R., Moller T. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J. Neurosci. 2000, 20:34-42.
36. Fern R., Ransom B.R., Waxman S.G. Voltage-gated calcium channels in CNS white matter: role in anoxic injury. J. Neurophysiol. 1995, 74:369-377.
37. Fields R.D., Burnstock G. Purinergic signalling in neuron-glia interactions. Nat. Rev. Neurosci. 2006, 7:423-436.
38. Fields R.D., Stevens B. ATP: an extracellular signaling molecule between neurons and glia. Trends Neurosci. 2000, 23:625-633.
39. Fleischer S., Inui M. Biochemistry and biophysics of excitation-contraction coupling. Annu. Rev. Biophys. Biophys. Chem. 1989, 18:333-364.
40. Fresu L., Dehpour A., Genazzani A.A., Carafoli E., Guerini D. Plasma membrane calcium ATPase isoforms in astrocytes. Glia 1999, 28:150-155.
41. Gellerman D.M., Bi X., Baudry M. NMDA receptor-mediated regulation of AMPA receptor properties in organotypic hippocampal slice cultures. J. Neurochem. 1997, 69:131-136.
42. George E.B., Glass J.D., Griffin J.W. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J. Neurosci. 1995, 15:6445-6452.
43. Ghosh A., Greenberg M.E. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 1995, 268:239-247.
44. 2+ as a key regulator of cell life and death. Cell Death Differ. 2007, 14:1267-1274.
45. 2+ exchangers NCX1-3 in neurons and astrocytes of adult rat brain in situ. Pharmacol. Res. 2007, 56:556-565.
46. Gogate N., Verma L., Zhou J.M., Milward E., Rusten R., O'Connor M., Kufta C., Kim J., Hudson L., Dubois-Dalcq M. Plasticity in the adult human oligodendrocyte lineage. J. Neurosci. 1994, 14:4571-4587.
47. Goldberg M.P., Ransom B.R. New light on white matter. Stroke 2003, 34:330-332.
48. Guo F., Maeda Y., Ko E.M., Delgado M., Horiuchi M., Soulika A., Miers L., Burns T., Itoh T., Shen H., Lee E., Sohn J., Pleasure D. Disruption of NMDA receptors in oligodendroglial lineage cells does not alter their susceptibility to experimental autoimmune encephalomyelitis or their normal development. J. Neurosci. 2012, 32:639-645.
49. Guyton M.K., Wingrave J.M., Yallapragada A.V., Wilford G.G., Sribnick E.A., Matzelle D.D., Tyor W.R., Ray S.K., Banik N.L. Upregulation of calpain correlates with increased neurodegeneration in acute experimental auto-immune encephalomyelitis. J. Neurosci. Res. 2005, 81:53-61.
50. Guyton M.K., Brahmachari S., Das A., Samantaray S., Inoue J., Azuma M., Ray S.K., Banik N.L. Inhibition of calpain attenuates encephalitogenicity of MBP-specific T cells. J. Neurochem. 2009, 110:1895-1907.
51. Gwarsha K., Rumsby M.G., Little C. Phospholipase C (Bacillus cereus) digestion of phospholipids in myelin isolated from central nervous tissue: removal of myelin basic protein increases exposure of lipids to the enzyme. Biochem. Soc. Trans. 1980, 8:600-601.
52. Gwarsha K., Rumsby M.G., Little C. Action of phospholipase C (Bacillus cereus) on isolated myelin sheath preparations. Neurochem. Int. 1984, 6:199-206.
53. Hagar R.E., Burgstahler A.D., Nathanson M.H., Ehrlich B.E. Type III InsP3 receptor channel stays open in the presence of increased calcium. Nature 1998, 396:81-84.
54. Hamilton N., Vayro S., Wigley R., Butt A.M. Axons and astrocytes release ATP and glutamate to evoke calcium signals in NG2-glia. Glia 2010, 58:66-79.
55. Harauz G., Musse A.A. A tale of two citrullines-structural and functional aspects of myelin basic protein deimination in health and disease. Neurochem. Res. 2007, 32:137-158.
56. Harding H.P., Calfon M., Urano F., Novoa I., Ron D. Transcriptional and translational control in the mammalian unfolded protein response. Annu. Rev. Cell Dev. Biol. 2002, 18:575-599.
57. Hazell A.S. Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies. Neurochem. Int. 2007, 50:941-953.
58. He L., Poblenz A.T., Medrano C.J., Fox D.A. Lead and calcium produce rod photoreceptor cell apoptosis by opening the mitochondrial permeability transition pore. J. Biol. Chem. 2000, 275:12175-12184.
59. Hell J.W., Westenbroek R.E., Breeze L.J., Wang K.K., Chavkin C., Catterall W.A. N-methyl-d-aspartate receptor-induced proteolytic conversion of postsynaptic class C L-type calcium channels in hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:3362-3367.
60. Heng S., Song A.W., Sim K. White matter abnormalities in bipolar disorder: insights from diffusion tensor imaging studies. J. Neural Transm. 2010, 117:639-654.
61. Huang Y.H., Bergles D.E. Glutamate transporters bring competition to the synapse. Curr. Opin. Neurobiol. 2004, 14:346-352.
62. 2+ channels in anoxic injury of spinal cord white matter. Brain Res. 1999, 817:84-92.
63. +-ATPase activity during early reperfusion contributes to cell death after myocardial ischemia. Circ. Res. 2005, 97:465-473.
64. Ishizaki Y., Tashiro T., Kurokawa M. A calcium-activated protease which preferentially degrades the 160-kDa component of the neurofilament triplet. Eur. J. Biochem. 1983, 131:41-45.
65. Iwata A., Stys P.K., Wolf J.A., Chen X.H., Taylor A.G., Meaney D.F., Smith D.H. Traumatic axonal injury induces proteolytic cleavage of the voltage-gated sodium channels modulated by tetrodotoxin and protease inhibitors. J. Neurosci. 2004, 24:4605-4613.
66. James G., Butt A.M. P2X and P2Y purinoreceptors mediate ATP-evoked calcium signalling in optic nerve glia in situ. Cell Calcium 2001, 30:251-259.
67. Jang I.S., Brodwick M.S., Wang Z.M., Jeong H.J., Choi B.J., Akaike N. The Na(+)/H(+) exchanger is a major pH regulator in GABAergic presynaptic nerve terminals synapsing onto rat CA3 pyramidal neurons. J. Neurochem. 2006, 99:1224-1236.
68. 2+ ATPase family members and associated synaptic proteins in acute and cultured organotypic hippocampal slices from rat. Brain Res. Dev. Brain Res. 2004, 152:129-136.
69. Jiang Q., Stys P.K. Calpain inhibitors confer biochemical, but not electrophysiological, protection against anoxia in rat optic nerves. J. Neurochem. 2000, 74:2101-2107.
70. Joseph B.S. Somatofugal events in Wallerian degeneration: a conceptual overview. Brain Res. 1973, 59:1-18.
71. Karadottir R., Attwell D. Neurotransmitter receptors in the life and death of oligodendrocytes. Neuroscience 2007, 145:1426-1438.
72. Karadottir R., Cavelier P., Bergersen L.H., Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005, 438:1162-1166.
73. Kaufman R.J. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 1999, 13:1211-1233.
74. Kayano T., Fukumoto H., Eddy R.L., Fan Y.S., Byers M.G., Shows T.B., Bell G.I. Evidence for a family of human glucose transporter-like proteins. Sequence and gene localization of a protein expressed in fetal skeletal muscle and other tissues. J. Biol. Chem. 1988, 263:15245-15248.
75. Kirichok Y., Krapivinsky G., Clapham D.E. The mitochondrial calcium uniporter is a highly selective ion channel. Nature 2004, 427:360-364.
76. Koeppen A.H. Wallerian degeneration: history and clinical significance. J. Neurol. Sci. 2004, 220:115-117.
77. Kukley M., Capetillo-Zarate E., Dietrich D. Vesicular glutamate release from axons in white matter. Nat. Neurosci. 2007, 10:311-320.
78. Lau A., Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 2010, 460:525-542.
79. Leino R.L., Gerhart D.Z., van Bueren A.M., McCall A.L., Drewes L.R. Ultrastructural localization of GLUT 1 and GLUT 3 glucose transporters in rat brain. J. Neurosci. Res. 1997, 49:617-626.
80. Leppanen L.L., Stys P.K. Ion transport and membrane potential in CNS myelinated axons. II: Effects of metabolic inhibition. J. Neurophysiol. 1997, 78:2095-2107.
81. Li S., Stys P.K. Na(+)-K(+)-ATPase inhibition and depolarization induce glutamate release via reverse Na(+)-dependent transport in spinal cord white matter. Neuroscience 2001, 107:675-683.
82. +-dependent glutamate transport. J. Neurosci. 1999, 19:RC16.
83. Lin W., Popko B. Endoplasmic reticulum stress in disorders of myelinating cells. Nat. Neurosci. 2009, 12:379-385.
84. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 1994, 330:613-622.
85. Lund-Andersen H. Transport of glucose from blood to brain. Physiol. Rev. 1979, 59:305-352.
86. Magnani P., Cherian P.V., Gould G.W., Greene D.A., Sima A.A., Brosius F.C. Glucose transporters in rat peripheral nerve: paranodal expression of GLUT1 and GLUT3. Metabolism 1996, 45:1466-1473.
87. Mangin J.M., Gallo V. The curious case of NG2 cells: transient trend or game changer?. ASN Neuro 2011, 3:e00052.
88. 2+-ATPase in the central nervous system: an EM cytochemical study. J. Histochem. Cytochem. 1989, 37:971-980.
89. Matute C. Oligodendrocyte NMDA receptors: a novel therapeutic target. Trends Mol. Med. 2006, 12:289-292.
90. Matute C. Glutamate and ATP signalling in white matter pathology. J. Anat. 2011, 219:53-64.
91. Matute C., Torre I., Perez-Cerda F., Perez-Samartin A., Alberdi E., Etxebarria E., Arranz A.M., Ravid R., Rodriguez-Antiguedad A., Sanchez-Gomez M., Domercq M. P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J. Neurosci. 2007, 27:9525-9533.
92. Maxwell W.L., McCreath B.J., Graham D.I., Gennarelli T.A. Cytochemical evidence for redistribution of membrane pump calcium-ATPase and ecto-Ca-ATPase activity, and calcium influx in myelinated nerve fibres of the optic nerve after stretch injury. J. Neurocytol. 1995, 24:925-942.
93. Mayer M.L. Glutamate receptor ion channels. Curr. Opin. Neurobiol. 2005, 15:282-288.
94. Mayer M.L., Westbrook G.L. Permeation and block of N-methyl-d-aspartic acid receptor channels by divalent cations in mouse cultured central neurones. J. Physiol. 1987, 394:501-527.
95. McDonald J.W., Althomsons S.P., Hyrc K.L., Choi D.W., Goldberg M.P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat. Med. 1998, 4:291-297.
96. McDonald J.W., Levine J.M., Qu Y. Multiple classes of the oligodendrocyte lineage are highly vulnerable to excitotoxicity. Neuroreport 1998, 9:2757-2762.
97. McEwen B.S., Reagan L.P. Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur. J. Pharmacol. 2004, 490:13-24.
98. McIntosh A.M., Munoz Maniega S., Lymer G.K., McKirdy J., Hall J., Sussmann J.E., Bastin M.E., Clayden J.D., Johnstone E.C., Lawrie S.M. White matter tractography in bipolar disorder and schizophrenia. Biol. Psychiatry 2008, 64:1088-1092.
99. Micu I., Coderre E., Jiang Q., Ridsdale A., Zhang L., Woulfe J., Yin X., Trapp B.D., McRory J.E., Rehak R., Zamponi G.W., Stys P.K. NMDA receptors mediate Ca accumulation in central nervous system myelin during chemical ischemia. Nature 2006, 439:988-992.
100. 2+ changes in CNS myelin by two-photon microscopy. Nat. Med. 2007, 13:874-879.
101. Moser H.W., Mahmood A., Raymond G.V. X-linked adrenoleukodystrophy. Nat. Clin. Pract. Neurol. 2007, 3:140-151.
102. Mosser J., Douar A.M., Sarde C.O., Kioschis P., Feil R., Moser H., Poustka A.M., Mandel J.L., Aubourg P. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993, 361:726-730.
103. Nave K.A. Myelination and support of axonal integrity by glia. Nature 2010, 468:244-252.
104. Nicholls D.G. Stochastic aspects of transmitter release and bioenergetic dysfunction in isolated nerve terminals. Biochem. Soc. Trans. 2010, 38:457-459.
105. Nicholls D., Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol. Sci. 1990, 11:462-468.
106. Nicholls D.G., Vesce S., Kirk L., Chalmers S. Interactions between mitochondrial bioenergetics and cytoplasmic calcium in cultured cerebellar granule cells. Cell Calcium 2003, 34:407-424.
107. Nikic I., Merkler D., Sorbara C., Brinkoetter M., Kreutzfeldt M., Bareyre F.M., Bruck W., Bishop D., Misgeld T., Kerschensteiner M. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat. Med. 2011, 17:495-499.
108. Nikolaev A., McLaughlin T., O'Leary D.D., Tessier-Lavigne M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009, 457:981-989.
109. 2+ release in rat optic nerve during in vitro chemical ischemia. J. Neurosci. 2005, 25:9960-9967.
110. Nikolaeva M.A., Richard S., Mouihate A., Stys P.K. Effects of the noradrenergic system in rat white matter exposed to oxygen-glucose deprivation in vitro. J. Neurosci. 2009, 29:1796-1804.
111. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
112. Nishio T. Axonal regeneration and neural network reconstruction in mammalian CNS. J. Neurol. 2009, 256(Suppl. 3):306-309.
113. Nishizaki T., Yamauchi R., Tanimoto M., Okada Y. Effects of temperature on the oxygen consumption in thin slices from different brain regions. Neurosci. Lett. 1988, 86:301-305.
114. 2+ channel activation of ryanodine receptors. Neuron 2003, 40:53-63.
115. 2+ stores during ischaemia in rat spinal cord white matter. J. Physiol. 2006, 577:191-204.
116. Ouardouz M., Coderre E., Zamponi G.W., Hameed S., Yin X., Trapp B.D., Stys P.K. Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors. Ann. Neurol. 2009, 65:160-166.
117. Ouardouz M., Coderre E., Basak A., Chen A., Zamponi G.W., Hameed S., Rehak R., Yin X., Trapp B.D., Stys P.K. Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors. Ann. Neurol. 2009, 65:151-159.
118. Pardridge W.M. Brain metabolism: a perspective from the blood-brain barrier. Physiol. Rev. 1983, 63:1481-1535.
119. Piña-Crespo J.C., Talantova M., Micu I., States B., Chen H.S., Tu S., Nakanishi N., Tong G., Zhang D., Heinemann S.F., Zamponi G.W., Stys P.K., Lipton S.A. Excitatory glycine responses of CNS myelin mediated by NR1/NR3 "NMDA" receptor subunits. J. Neurosci. 2010, 30:11501-11505.
120. Polten A., Fluharty A.L., Fluharty C.B., Kappler J., von Figura K., Gieselmann V. Molecular basis of different forms of metachromatic leukodystrophy. N. Engl. J. Med. 1991, 324:18-22.
121. Potter D.A., Tirnauer J.S., Janssen R., Croall D.E., Hughes C.N., Fiacco K.A., Mier J.W., Maki M., Herman I.M. Calpain regulates actin remodeling during cell spreading. J. Cell Biol. 1998, 141:647-662.
122. Raff M.C., Whitmore A.V., Finn J.T. Axonal self-destruction and neurodegeneration. Science 2002, 296:868-871.
123. Ransom B.R., Fern R. Does astrocytic glycogen benefit axon function and survival in CNS white matter during glucose deprivation?. Glia 1997, 21:134-141.
124. Ray S.K., Banik N.L. Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr. Drug Targets CNS Neurol. Disord. 2003, 2:173-189.
125. Rinholm J.E., Hamilton N.B., Kessaris N., Richardson W.D., Bergersen L.H., Attwell D. Regulation of oligodendrocyte development and myelination by glucose and lactate. J. Neurosci. 2011, 31:538-548.
126. Rossi D.J., Oshima T., Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 2000, 403:316-321.
127. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16:675-686.
128. Rozas J.L., Paternain A.V., Lerma J. Noncanonical signaling by ionotropic kainate receptors. Neuron 2003, 39:543-553.
129. 2+ release through ryanodine receptors contributes to AMPA receptor-mediated mitochondrial dysfunction and ER stress in oligodendrocytes. Cell Death Dis. 2010, 1:e54.
130. Rutkowski D.T., Kaufman R.J. A trip to the ER: coping with stress. Trends Cell Biol. 2004, 14:20-28.
131. Saatman K.E., Bozyczko-Coyne D., Marcy V., Siman R., McIntosh T.K. Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J. Neuropathol. Exp. Neurol. 1996, 55:850-860.
132. Salamino F., Sparatore B., Melloni E., Michetti M., Viotti P.L., Pontremoli S., Carafoli E. The plasma membrane calcium pump is the preferred calpain substrate within the erythrocyte. Cell Calcium 1994, 15:28-35.
133. Salter M.G., Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 2005, 438:1167-1171.
134. Sanchez-Abarca L.I., Tabernero A., Medina J.M. Oligodendrocytes use lactate as a source of energy and as a precursor of lipids. Glia 2001, 36:321-329.
135. Scholz J., Klein M.C., Behrens T.E., Johansen-Berg H. Training induces changes in white-matter architecture. Nat. Neurosci. 2009, 12:1370-1371.
136. Schumacher P.A., Siman R.G., Fehlings M.G. Pretreatment with calpain inhibitor CEP-4143 inhibits calpain I activation and cytoskeletal degradation, improves neurological function, and enhances axonal survival after traumatic spinal cord injury. J. Neurochem. 2000, 74:1646-1655.
137. Sheldon A.L., Robinson M.B. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem. Int. 2007, 51:333-355.
138. Shields D.C., Banik N.L. Pathophysiological role of calpain in experimental demyelination. J. Neurosci. Res. 1999, 55:533-541.
139. Shields D.C., Schaecher K.E., Saido T.C., Banik N.L. A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:11486-11491.
140. Sloane J.A., Hinman J.D., Lubonia M., Hollander W., Abraham C.R. Age-dependent myelin degeneration and proteolysis of oligodendrocyte proteins is associated with the activation of calpain-1 in the rhesus monkey. J. Neurochem. 2003, 84:157-168.
141. Stirling D.P., Stys P.K. Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation. Trends Mol. Med. 2010, 16:160-170.
142. Stys P.K. Axonal degeneration in MS: is it time for neuroprotective strategies?. Ann. Neurol. 2004, 55:601-603.
143. Stys P.K. General mechanisms of axonal damage and its prevention. J. Neurol. Sci. 2005, 233:3-13.
144. Stys P.K. The axo-myelinic synapse. Trends Neurosci. 2011, 34:393-400.
145. Stys P.K., Lipton S.A. White matter NMDA receptors: an unexpected new therapeutic target?. Trends Pharmacol. Sci. 2007, 28:561-566.
146. Stys P.K., LoPachin R.M. Mechanisms of ion flux in anoxic myelinated CNS axons. Neuroscience 1998, 82:21-32.
147. Stys P.K., Ransom B.R., Waxman S.G., Davis P.K. Role of extracellular calcium in anoxic injury of mammalian central white matter. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:4212-4216.
148. 2+ exchanger. J. Neurosci. 1992, 12:430-439.
149. + conductance in rat optic nerve axons. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:6976-6980.
150. Takei K., Stukenbrok H., Metcalf A., Mignery G.A., Sudhof T.C., Volpe P., De Camilli P. Ca2+ stores in Purkinje neurons: endoplasmic reticulum subcompartments demonstrated by the heterogeneous distribution of the InsP3 receptor, Ca(2+)-ATPase, and calsequestrin. J. Neurosci. 1992, 12:489-505.
151. Takeuchi H., Sekiguchi A., Taki Y., Yokoyama S., Yomogida Y., Komuro N., Yamanouchi T., Suzuki S., Kawashima R. Training of working memory impacts structural connectivity. J. Neurosci. 2010, 30:3297-3303.
152. Taubert M., Draganski B., Anwander A., Muller K., Horstmann A., Villringer A., Ragert P. Dynamic properties of human brain structure: learning-related changes in cortical areas and associated fiber connections. J. Neurosci. 2010, 30:11670-11677.
153. Tekkok S.B., Brown A.M., Westenbroek R., Pellerin L., Ransom B.R. Transfer of glycogen-derived lactate from astrocytes to axons via specific monocarboxylate transporters supports mouse optic nerve activity. J. Neurosci. Res. 2005, 81:644-652.
154. Tekkok S.B., Ye Z., Ransom B.R. Excitotoxic mechanisms of ischemic injury in myelinated white matter. J. Cereb. Blood Flow Metab. 2007, 1540-1552.
155. Thayer S.A., Miller R.J. Regulation of the intracellular free calcium concentration in single rat dorsal root ganglion neurones in vitro. J. Physiol. 1990, 425:85-115.
156. Trapp B.D., Stys P.K. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 2009, 8:280-291.
157. Tsukita S., Ishikawa H. Three-dimensional distribution of smooth endoplasmic reticulum in myelinated axons. J. Electron Microsc. (Tokyo) 1976, 25:141-149.
158. Vergo S., Craner M.J., Etzensperger R., Attfield K., Friese M.A., Newcombe J., Esiri M., Fugger L. Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model. Brain 2011, 134:571-584.
159. Verkhratsky A. Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiol. Rev. 2005, 85:201-279.
160. von Reyn C.R., Spaethling J.M., Mesfin M.N., Ma M., Neumar R.W., Smith D.H., Siman R., Meaney D.F. Calpain mediates proteolysis of the voltage-gated sodium channel alpha-subunit. J. Neurosci. 2009, 29:10350-10356.
161. Wake H., Lee P.R., Fields R.D. Control of local protein synthesis and initial events in myelination by action potentials. Science 2011, 333:1647-1651.
162. Waxman S.G., Black J.A., Ransom B.R., Stys P.K. Protection of the axonal cytoskeleton in anoxic optic nerve by decreased extracellular calcium. Brain Res. 1993, 614:137-145.
163. Wenger D.A., Rafi M.A., Luzi P., Datto J., Costantino-Ceccarini E. Krabbe disease: genetic aspects and progress toward therapy. Mol. Genet. Metab. 2000, 70:1-9.
164. White T., Nelson M., Lim K.O. Diffusion tensor imaging in psychiatric disorders. Top. Magn. Reson. Imaging 2008, 19:97-109.
165. Wisden W., Seeburg P.H. Mammalian ionotropic glutamate receptors. Curr. Opin. Neurobiol. 1993, 3:291-298.
166. Wood D.D., Ackerley C.A., Brand B., Zhang L., Raijmakers R., Mastronardi F.G., Moscarello M.A. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities. Lab. Invest. 2008, 88:354-364.
167. 2+ exchange currents in cortical neurons: concomitant forward and reverse operation and effect of glutamate. Eur. J. Neurosci. 1997, 9:1273-1281.
168. Yu S., Ding W.G. The 45kDa form of glucose transporter 1 (GLUT1) is localized in oligodendrocyte and astrocyte but not in microglia in the rat brain. Brain Res. 1998, 797:65-72.
169. Zhang K., Sejnowski T.J. A universal scaling law between gray matter and white matter of cerebral cortex. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:5621-5626.
170. Zhang C., Shen W., Zhang G. N-methyl-d-aspartate receptor and L-type voltage-gated Ca(2+) channel antagonists suppress the release of cytochrome c and the expression of procaspase-3 in rat hippocampus after global brain ischemia. Neurosci. Lett. 2002, 328:265-268.
171. Ziak D., Chvatal A., Sykova E. Glutamate-, kainate- and NMDA-evoked membrane currents in identified glial cells in rat spinal cord slice. Physiol. Res. 1998, 47:365-375.
172. Ziskin J.L., Nishiyama A., Rubio M., Fukaya M., Bergles D.E. Vesicular release of glutamate from unmyelinated axons in white matter. Nat. Neurosci. 2007, 10:321-330.